ibritumomab tiuxetan   Click here for help

GtoPdb Ligand ID: 6777

Synonyms: IDEC-2B8 | IDEC-Y2B8-yttrium ibritumomab tiuxetan | NSC-715848 | Zevalin®
Approved drug Immunopharmacology Ligand
ibritumomab tiuxetan is an approved drug (FDA (2002), EMA (2004))
Compound class: Antibody
Comment: A monoclonal antibody used as a radioimmunotherapy treatment.
1. Chinn PC, Leonard JE, Rosenberg J, Hanna N, Anderson DR. (1999)
Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma.
Int J Oncol, 15 (5): 1017-25. [PMID:10536187]